Haemonetics | HAE - Operating Profit

Stock Price
65.47
Daily Change
-1.19 -1.79%
Monthly
-20.27%
Yearly
-1.03%
Q1 Forecast
64.61

Haemonetics reported $58.49M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Avanos Medical USD 18.97M 72.63M Sep/2025
Baxter International USD 201.2M 70.8M Sep/2025
Becton, Dickinson and Co. USD 826M 153M Sep/2025
Boston Scientific USD 1.04B 98M Sep/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 449.94M 18.94M Sep/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Haemonetics USD 58.49M 12.35M Sep/2025
Hologic USD 237M 16M Dec/2025
ICU Medical USD 26.86M 52K Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
Masimo USD 83.6M 19.1M Sep/2025
Medtronic USD 1.7B 100M Sep/2025
Merit Medical Systems USD 42.61M 4.41M Sep/2025
Neogen USD -5.38M 10.71M Sep/2025
Quidel USD -704.8M 703M Sep/2025
ResMed USD 497.6M 35.25M Dec/2025
STAAR Surgical USD 18.49M 43.21M Sep/2025
Steris USD 270.9M 45.6M Sep/2025
Stryker USD 1.97B 609M Dec/2025
Teleflex USD -408.9M 586.38M Sep/2025
Terumo JPY 45.1B 10.79B Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
US Physical Therapy USD 25.29M 281K Sep/2025
Zimmer Biomet Holdings USD 338.3M 58.1M Sep/2025